Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Extending Adjuvant Endocrine Therapy in Breast Cancer: Who, What, Why?

Vinayak S, Davidson NE.

Oncology (Williston Park). 2019 Jun 19;33(6):243-6.

2.

Open-Label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer.

Vinayak S, Tolaney SM, Schwartzberg L, Mita M, McCann G, Tan AR, Wahner-Hendrickson AE, Forero A, Anders C, Wulf GM, Dillon P, Lynce F, Zarwan C, Erban JK, Zhou Y, Buerstatte N, Graham JR, Arora S, Dezube BJ, Telli ML.

JAMA Oncol. 2019 Jun 13. doi: 10.1001/jamaoncol.2019.1029. [Epub ahead of print]

PMID:
31194225
3.

Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis.

Baragaña B, Forte B, Choi R, Nakazawa Hewitt S, Bueren-Calabuig JA, Pisco JP, Peet C, Dranow DM, Robinson DA, Jansen C, Norcross NR, Vinayak S, Anderson M, Brooks CF, Cooper CA, Damerow S, Delves M, Dowers K, Duffy J, Edwards TE, Hallyburton I, Horst BG, Hulverson MA, Ferguson L, Jiménez-Díaz MB, Jumani RS, Lorimer DD, Love MS, Maher S, Matthews H, McNamara CW, Miller P, O'Neill S, Ojo KK, Osuna-Cabello M, Pinto E, Post J, Riley J, Rottmann M, Sanz LM, Scullion P, Sharma A, Shepherd SM, Shishikura Y, Simeons FRC, Stebbins EE, Stojanovski L, Straschil U, Tamaki FK, Tamjar J, Torrie LS, Vantaux A, Witkowski B, Wittlin S, Yogavel M, Zuccotto F, Angulo-Barturen I, Sinden R, Baum J, Gamo FJ, Mäser P, Kyle DE, Winzeler EA, Myler PJ, Wyatt PG, Floyd D, Matthews D, Sharma A, Striepen B, Huston CD, Gray DW, Fairlamb AH, Pisliakov AV, Walpole C, Read KD, Van Voorhis WC, Gilbert IH.

Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7015-7020. doi: 10.1073/pnas.1814685116. Epub 2019 Mar 20.

4.

Future of checkpoint blockade in triple-negative breast cancer: combination strategies to lead the way.

Telli ML, Vinayak S.

Ann Oncol. 2019 Mar 1;30(3):347-348. doi: 10.1093/annonc/mdz040. No abstract available.

PMID:
30753266
5.

Difficulties in diagnosis of Riedel's thyroiditis on aspiration cytology: A case report and brief review of the literature.

Kumar N, Gupta R, Sayed S, Moloo Z, Vinayak S, Ahmed M.

Diagn Cytopathol. 2019 May;47(5):512-516. doi: 10.1002/dc.24130. Epub 2018 Dec 27.

PMID:
30589235
6.

Medical Student Ultrasound Education: A WFUMB Position Paper, Part I.

Dietrich CF, Hoffmann B, Abramowicz J, Badea R, Braden B, Cantisani V, Chammas MC, Cui XW, Dong Y, Gilja OH, Hari R, Nisenbaum H, Nicholls D, Nolsøe CP, Nürnberg D, Prosch H, Radzina M, Recker F, Sachs A, Saftoiu A, Serra A, Sweet L, Vinayak S, Westerway S, Chou YH, Blaivas M.

Ultrasound Med Biol. 2019 Feb;45(2):271-281. doi: 10.1016/j.ultrasmedbio.2018.09.017. Epub 2018 Nov 27. Review.

PMID:
30497768
7.

Collaborative task-sharing to enhance the Point-Of-Care Ultrasound (POCUS) access among expectant women in Kenya: The role of midwife sonographers.

Vinayak S, Brownie S.

J Interprof Care. 2018 Sep;32(5):641-644. doi: 10.1080/13561820.2018.1470499. Epub 2018 May 10.

PMID:
29746179
8.

A breast multi-disciplinary genomic tumor board is feasible and can provide timely and impactful recommendations.

Tsung K, Thompson CL, Knight JM, Maximuk S, Sadri N, Gilmore H, Keri RA, Vinayak S, Harris L, Silverman P.

Breast J. 2018 Jul;24(4):676-677. doi: 10.1111/tbj.13027. Epub 2018 Mar 8. No abstract available.

PMID:
29517142
9.

Retrospective Evaluation of Factors Related to the Outcomes of Regenerative Therapy for Implants Affected by Peri-implantitis.

Froum SJ, Rosen PS, Wang WC, Froum SH, Vinayak S.

Int J Periodontics Restorative Dent. 2018 Mar/Apr;38(2):181-187. doi: 10.11607/prd.3489.

PMID:
29447310
10.

Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer.

Telli ML, Hellyer J, Audeh W, Jensen KC, Bose S, Timms KM, Gutin A, Abkevich V, Peterson RN, Neff C, Hughes E, Sangale Z, Jones J, Hartman AR, Chang PJ, Vinayak S, Wenstrup R, Ford JM.

Breast Cancer Res Treat. 2018 Apr;168(3):625-630. doi: 10.1007/s10549-017-4624-7. Epub 2017 Dec 23.

PMID:
29275435
11.

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.

Doherty MR, Cheon H, Junk DJ, Vinayak S, Varadan V, Telli ML, Ford JM, Stark GR, Jackson MW.

Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):13792-13797. doi: 10.1073/pnas.1713728114. Epub 2017 Dec 11.

12.

Role of Platinum in Early-Stage Triple-Negative Breast Cancer.

La Belle A, Khatib J, Schiemann WP, Vinayak S.

Curr Treat Options Oncol. 2017 Nov 6;18(11):68. doi: 10.1007/s11864-017-0506-9. Review.

PMID:
29110096
13.

Ethnicity and breast cancer characteristics in Kenya.

Sayed S, Moloo Z, Wasike R, Bird P, Oigara R, Njoroge FW, Shaikh AJ, Prasad SV, Vinayak S, Gierach GL, Dawsey SM, Palakal M, Fan S, Mullooly M, Chauhan R, Okiro P, Gakinya S, Nzioka A, Kyobutungi C, Mohamed S, Haregu T, Mussajee M, Bonass B, Mariwa C, Sherman OA, Mohammed A, Gachii A, Githaiga J, Karanu J, Nyagah R, Njoroge R, Muramba I, Otieno JO, Raburu DO, Mwachiro EB, Abayo I, Saleh M.

Breast Cancer Res Treat. 2018 Jan;167(2):425-437. doi: 10.1007/s10549-017-4511-2. Epub 2017 Sep 26.

14.

Generating and Maintaining Transgenic Cryptosporidium parvum Parasites.

Pawlowic MC, Vinayak S, Sateriale A, Brooks CF, Striepen B.

Curr Protoc Microbiol. 2017 Aug 11;46:20B.2.1-20B.2.32. doi: 10.1002/cpmc.33.

15.

Training Midwives to Perform Basic Obstetric Point-of-Care Ultrasound in Rural Areas Using a Tablet Platform and Mobile Phone Transmission Technology-A WFUMB COE Project.

Vinayak S, Sande J, Nisenbaum H, Nolsøe CP.

Ultrasound Med Biol. 2017 Oct;43(10):2125-2132. doi: 10.1016/j.ultrasmedbio.2017.05.024. Epub 2017 Jul 14.

16.

Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide.

Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, López-Ridaura R, Rice M, Pereira A, Garmendia ML, Tamimi RM, Bertrand K, Kwong A, Ursin G, Lee E, Qureshi SA, Ma H, Vinnicombe S, Moss S, Allen S, Ndumia R, Vinayak S, Teo SH, Mariapun S, Fadzli F, Peplonska B, Bukowska A, Nagata C, Stone J, Hopper J, Giles G, Ozmen V, Aribal ME, Schüz J, Van Gils CH, Wanders JOP, Sirous R, Sirous M, Hipwell J, Kim J, Lee JW, Dickens C, Hartman M, Chia KS, Scott C, Chiarelli AM, Linton L, Pollan M, Flugelman AA, Salem D, Kamal R, Boyd N, Dos-Santos-Silva I, McCormack V.

PLoS Med. 2017 Jun 30;14(6):e1002335. doi: 10.1371/journal.pmed.1002335. eCollection 2017 Jun.

17.

Opportunities and Challenges in Realizing Universal Access to Obstetric Ultrasound in Sub-Saharan Africa.

Wanyonyi SZ, Mariara CM, Vinayak S, Stones W.

Ultrasound Int Open. 2017 Apr;3(2):E52-E59. doi: 10.1055/s-0043-103948. Epub 2017 Jun 7. Review.

18.

Antenatal Umbilical Coiling Index and Newborn Outcomes: Cohort Study.

Ndolo JM, Vinayak S, Silaba MO, Stones W.

J Clin Imaging Sci. 2017 May 22;7:21. doi: 10.4103/jcis.JCIS_111_16. eCollection 2017.

19.

A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.

Manjunatha UH, Vinayak S, Zambriski JA, Chao AT, Sy T, Noble CG, Bonamy GMC, Kondreddi RR, Zou B, Gedeck P, Brooks CF, Herbert GT, Sateriale A, Tandel J, Noh S, Lakshminarayana SB, Lim SH, Goodman LB, Bodenreider C, Feng G, Zhang L, Blasco F, Wagner J, Leong FJ, Striepen B, Diagana TT.

Nature. 2017 Jun 15;546(7658):376-380. doi: 10.1038/nature22337. Epub 2017 May 31.

20.

Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection.

Arnold SLM, Choi R, Hulverson MA, Schaefer DA, Vinayak S, Vidadala RSR, McCloskey MC, Whitman GR, Huang W, Barrett LK, Ojo KK, Fan E, Maly DJ, Riggs MW, Striepen B, Van Voorhis WC.

J Infect Dis. 2017 Jul 1;216(1):55-63. doi: 10.1093/infdis/jix247.

21.

Thyroid Ultrasound: State of the Art. Part 2 - Focal Thyroid Lesions.

Dighe M, Barr R, Bojunga J, Cantisani V, Chammas MC, Cosgrove D, Cui XW, Dong Y, Fenner F, Radzina M, Vinayak S, Xu JM, Dietrich CF.

Med Ultrason. 2017 Apr 22;19(2):195-210. doi: 10.11152/mu-999. Review.

22.

Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.

Hulverson MA, Vinayak S, Choi R, Schaefer DA, Castellanos-Gonzalez A, Vidadala RSR, Brooks CF, Herbert GT, Betzer DP, Whitman GR, Sparks HN, Arnold SLM, Rivas KL, Barrett LK, White AC Jr, Maly DJ, Riggs MW, Striepen B, Van Voorhis WC, Ojo KK.

J Infect Dis. 2017 Apr 15;215(8):1275-1284. doi: 10.1093/infdis/jix120. Erratum in: J Infect Dis. 2018 Jan 4;217(2):340.

23.

Thyroid Ultrasound: State of the Art Part 1 - Thyroid Ultrasound reporting and Diffuse Thyroid Diseases.

Dighe M, Barr R, Bojunga J, Cantisani V, Chammas MC, Cosgrove D, Cui XW, Dong Y, Fenner F, Radzina M, Vinayak S, Xu JM, Dietrich CF.

Med Ultrason. 2017 Jan 31;19(1):79-93. doi: 10.11152/mu-980. Review.

24.

Ultrasound shear wave elastography and liver fibrosis: A Prospective Multicenter Study.

Sande JA, Verjee S, Vinayak S, Amersi F, Ghesani M.

World J Hepatol. 2017 Jan 8;9(1):38-47. doi: 10.4254/wjh.v9.i1.38.

25.

Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance.

Afghahi A, Timms KM, Vinayak S, Jensen KC, Kurian AW, Carlson RW, Chang PJ, Schackmann E, Hartman AR, Ford JM, Telli ML.

Clin Cancer Res. 2017 Jul 1;23(13):3365-3370. doi: 10.1158/1078-0432.CCR-16-2174. Epub 2017 Jan 13.

26.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Merajver SD, Offit K, Pal T, Reiser G, Shannon KM, Swisher E, Vinayak S, Voian NC, Weitzel JN, Wick MJ, Wiesner GL, Dwyer M, Darlow S.

J Natl Compr Canc Netw. 2017 Jan;15(1):9-20.

PMID:
28040716
27.

Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems.

Burton A, Byrnes G, Stone J, Tamimi RM, Heine J, Vachon C, Ozmen V, Pereira A, Garmendia ML, Scott C, Hipwell JH, Dickens C, Schüz J, Aribal ME, Bertrand K, Kwong A, Giles GG, Hopper J, Pérez Gómez B, Pollán M, Teo SH, Mariapun S, Taib NA, Lajous M, Lopez-Riduara R, Rice M, Romieu I, Flugelman AA, Ursin G, Qureshi S, Ma H, Lee E, Sirous R, Sirous M, Lee JW, Kim J, Salem D, Kamal R, Hartman M, Miao H, Chia KS, Nagata C, Vinayak S, Ndumia R, van Gils CH, Wanders JO, Peplonska B, Bukowska A, Allen S, Vinnicombe S, Moss S, Chiarelli AM, Linton L, Maskarinec G, Yaffe MJ, Boyd NF, Dos-Santos-Silva I, McCormack VA.

Breast Cancer Res. 2016 Dec 19;18(1):130.

28.

WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography: Part 4. Thyroid.

Cosgrove D, Barr R, Bojunga J, Cantisani V, Chammas MC, Dighe M, Vinayak S, Xu JM, Dietrich CF.

Ultrasound Med Biol. 2017 Jan;43(1):4-26. doi: 10.1016/j.ultrasmedbio.2016.06.022. Epub 2016 Aug 25. Review.

PMID:
27570210
29.

Point of Care Ultrasound: A WFUMB Position Paper.

Dietrich CF, Goudie A, Chiorean L, Cui XW, Gilja OH, Dong Y, Abramowicz JS, Vinayak S, Westerway SC, Nolsøe CP, Chou YH, Blaivas M.

Ultrasound Med Biol. 2017 Jan;43(1):49-58. doi: 10.1016/j.ultrasmedbio.2016.06.021. Epub 2016 Jul 26. Review.

PMID:
27472989
31.

Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab.

Gollamudi J, Parvani JG, Schiemann WP, Vinayak S.

Cancer Manag Res. 2016 Feb 18;8:21-31. doi: 10.2147/CMAR.S55279. eCollection 2016. Review.

32.

¹⁸F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.

Avril S, Muzic RF Jr, Plecha D, Traughber BJ, Vinayak S, Avril N.

J Nucl Med. 2016 Feb;57 Suppl 1:34S-9S. doi: 10.2967/jnumed.115.157875. Review.

33.

International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries.

McCormack VA, Burton A, dos-Santos-Silva I, Hipwell JH, Dickens C, Salem D, Kamal R, Hartman M, Lee CP, Chia KS, Ozmen V, Aribal ME, Flugelman AA, Lajous M, Lopez-Riduara R, Rice M, Romieu I, Ursin G, Qureshi S, Ma H, Lee E, van Gils CH, Wanders JO, Vinayak S, Ndumia R, Allen S, Vinnicombe S, Moss S, Won Lee J, Kim J, Pereira A, Garmendia ML, Sirous R, Sirous M, Peplonska B, Bukowska A, Tamimi RM, Bertrand K, Nagata C, Kwong A, Vachon C, Scott C, Perez-Gomez B, Pollan M, Maskarinec G, Giles G, Hopper J, Stone J, Rajaram N, Teo SH, Mariapun S, Yaffe MJ, Schüz J, Chiarelli AM, Linton L, Boyd NF.

Cancer Epidemiol. 2016 Feb;40:141-51. doi: 10.1016/j.canep.2015.11.015. Epub 2015 Dec 24.

34.

Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum.

Vinayak S, Pawlowic MC, Sateriale A, Brooks CF, Studstill CJ, Bar-Peled Y, Cipriano MJ, Striepen B.

Nature. 2015 Jul 23;523(7561):477-80. doi: 10.1038/nature14651. Epub 2015 Jul 15.

35.

Uterine fibroid embolization for symptomatic fibroids: study at a teaching hospital in kenya.

Mutai JK, Vinayak S, Stones W, Hacking N, Mariara C.

J Clin Imaging Sci. 2015 Mar 31;5:18. doi: 10.4103/2156-7514.154351. eCollection 2015.

36.

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.

Telli ML, Jensen KC, Vinayak S, Kurian AW, Lipson JA, Flaherty PJ, Timms K, Abkevich V, Schackmann EA, Wapnir IL, Carlson RW, Chang PJ, Sparano JA, Head B, Goldstein LJ, Haley B, Dakhil SR, Reid JE, Hartman AR, Manola J, Ford JM.

J Clin Oncol. 2015 Jun 10;33(17):1895-901. doi: 10.1200/JCO.2014.57.0085. Epub 2015 Apr 6.

37.

Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers.

Watkins J, Weekes D, Shah V, Gazinska P, Joshi S, Sidhu B, Gillett C, Pinder S, Vanoli F, Jasin M, Mayrhofer M, Isaksson A, Cheang MC, Mirza H, Frankum J, Lord CJ, Ashworth A, Vinayak S, Ford JM, Telli ML, Grigoriadis A, Tutt AN.

Cancer Discov. 2015 May;5(5):488-505. doi: 10.1158/2159-8290.CD-14-1092. Epub 2015 Mar 13.

38.

Genetic manipulation of the Toxoplasma gondii genome by fosmid recombineering.

Vinayak S, Brooks CF, Naumov A, Suvorova ES, White MW, Striepen B.

MBio. 2014 Dec 2;5(6):e02021. doi: 10.1128/mBio.02021-14.

39.

The role of inflammation in contrast-induced nephropathy.

Kwasa EA, Vinayak S, Armstrong R.

Br J Radiol. 2014 Sep;87(1041):20130738. doi: 10.1259/bjr.20130738. Epub 2014 Jul 10.

40.

A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.

Vinayak S, Schwartz EJ, Jensen K, Lipson J, Alli E, McPherson L, Fernandez AM, Sharma VB, Staton A, Mills MA, Schackmann EA, Telli ML, Kardashian A, Ford JM, Kurian AW.

Breast Cancer Res Treat. 2013 Nov;142(2):389-98. doi: 10.1007/s10549-013-2739-z. Epub 2013 Oct 29.

41.

A nucleolar AAA-NTPase is required for parasite division.

Suvorova ES, Radke JB, Ting LM, Vinayak S, Alvarez CA, Kratzer S, Kim K, Striepen B, White MW.

Mol Microbiol. 2013 Oct;90(2):338-55. doi: 10.1111/mmi.12367. Epub 2013 Sep 11.

42.
43.

Implementation of the INTERGROWTH-21st Project in Kenya.

Carvalho M, Vinayak S, Ochieng R, Choksey V, Musee N, Stones W, Knight H, Cheikh Ismail L; International Fetal and Newborn Growth Consortium for the 21st Century.

BJOG. 2013 Sep;120 Suppl 2:105-10, v. doi: 10.1111/1471-0528.12045. Epub 2013 May 16.

44.

mTOR inhibitors in the treatment of breast cancer.

Vinayak S, Carlson RW.

Oncology (Williston Park). 2013 Jan;27(1):38-44, 46, 48 passim. Review.

45.

Breast cancer diagnosis in a resource poor environment through a collaborative multidisciplinary approach: the Kenyan experience.

Sayed S, Moloo Z, Bird P, Wasike R, Njoroge W, Karanu J, Nzioka A, Sherman O, Prasad S, Mariwa C, Otieno JO, Chumba D, Koech D, Mbinga D, Mohammed M, Njoroge R, Chauhan R, Vinayak S, Kyobutungi C, Saleh M.

J Clin Pathol. 2013 Apr;66(4):307-11. doi: 10.1136/jclinpath-2012-201404. Epub 2013 Feb 1.

PMID:
23378268
46.

Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.

Zeeshan M, Alam MT, Vinayak S, Bora H, Tyagi RK, Alam MS, Choudhary V, Mittra P, Lumb V, Bharti PK, Udhayakumar V, Singh N, Jain V, Singh PP, Sharma YD.

PLoS One. 2012;7(8):e43430. doi: 10.1371/journal.pone.0043430. Epub 2012 Aug 17.

47.

Avoiding unnecessary fine-needle aspiration cytology by accuractely predicting the benign nature of thyroid nodules using ultrasound.

Vinayak S, Sande JA.

J Clin Imaging Sci. 2012;2:23. doi: 10.4103/2156-7514.95446. Epub 2012 Apr 28.

48.

Diagnosis of Langerhans cell histiocytosis on fine needle aspiration cytology: a case report and review of the cytology literature.

Kumar N, Sayed S, Vinayak S.

Patholog Res Int. 2011 Jan 20;2011:439518. doi: 10.4061/2011/439518.

49.

Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.

Alam MT, de Souza DK, Vinayak S, Griffing SM, Poe AC, Duah NO, Ghansah A, Asamoa K, Slutsker L, Wilson MD, Barnwell JW, Udhayakumar V, Koram KA.

J Infect Dis. 2011 Jan 15;203(2):220-7. doi: 10.1093/infdis/jiq038.

50.

Comparison of Doppler studies in obstetrics with foetal outcome.

Waa S, Vinayak S.

East Afr Med J. 2010 Dec;87(12):502-8.

PMID:
23457860

Supplemental Content

Loading ...
Support Center